¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå ¼ºÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)
Immunomodulators Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
»óǰÄÚµå : 1621833
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 110 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸é¿ªÁ¶ÀýÁ¦ ¼¼°è ½ÃÀåÀº 2023³â 2,177¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³â°£ ¿¬Æò±Õ 6.7% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸é¿ª Á¶ÀýÁ¦´Â ¸é¿ª°è Ȱµ¿À» °­È­(¸é¿ª Ȱ¼ºÈ­Á¦) ¶Ç´Â ¾ïÁ¦(¸é¿ª ¾ïÁ¦Á¦)ÇÏ´Â ¸é¿ª Á¶ÀýÁ¦´Â ÀÚ°¡¸é¿ª Áúȯ, ¾Ï, ¸¸¼º °¨¿° µîÀÇ Ä¡·á¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÚ°¡¸é¿ªÁúȯ ¹× ¿°Áõ¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, »ý¸í°øÇÐ ¹× Á¦¾à ¿¬±¸ ¹ßÀü, ¸é¿ªÁ¶Àý¿ä¹ý¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî ¿©·¯ ¿äÀÎÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Äڷγª ÀÌÈÄ ÇÕº´ÁõÀÌ ±ÞÁõÇϸ鼭 ¸é¿ª Á¶ÀýÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·áÁ¦´Â Àå±âÀûÀΠȣÈí±â Áúȯ ¹× ±âŸ °Ç°­ ¹®Á¦¸¦ °ü¸®ÇÏ´Â µ¥ »ç¿ëµÇ±â ¶§¹®ÀÔ´Ï´Ù.

½ÃÀåÀº Å©°Ô ¸é¿ª¾ïÁ¦Á¦¿Í ¸é¿ªÁõ°­Á¦ÀÇ µÎ °¡Áö Á¦Ç° À¯ÇüÀ¸·Î ³ª´µ¸ç, 2023³â 1,365¾ï ´Þ·¯·Î °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÑ ¸é¿ª¾ïÁ¦Á¦´Â ¿¹Ãø ±â°£ µ¿¾È ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº Àü ¼¼°è Àå±â À̽ķü Áõ°¡¿¡ µû¸¥ Àå±â ÀÌ½Ä ¾àǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¸é¿ª¾ïÁ¦Á¦´Â Àå±â °ÅºÎ¹ÝÀÀÀ» ¿¹¹æÇÏ°í ¼º°øÀûÀÎ À̽ÄÀ» À§ÇØ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¸é¿ª¾ïÁ¦Á¦ ½ÃÀåÀ» ¿ëµµº°·Î ºÐ·ùÇÏ¸é ¾Ï, ÀÚ°¡¸é¿ªÁúȯ, °¨¿°¼º Áúȯ, ±âŸ ¿ëµµ°¡ ÀÖÀ¸¸ç, 2023³â ½ÃÀå ±Ô¸ð´Â 854¾ï ´Þ·¯·Î ¾Ï ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ¸é¿ª Á¶ÀýÁ¦´Â ¾Ï¼¼Æ÷¸¦ Ç¥ÀûÀ¸·Î »ï¾Æ ÆÄ±«ÇÏ´Â ¸é¿ª ü°èÀÇ ´É·ÂÀ» °­È­Çϱâ À§ÇØ ¾Ï Ä¡·á¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¸é¿ª°ü¹®¾ïÁ¦Á¦, »çÀÌÅäÄ«ÀÎ, ¾Ï ¹é½Å µîÀ» Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ Ä¡·á¹ýÀº Á¾¾ç°ú ´õ È¿°úÀûÀ¸·Î ½Î¿ì±â À§ÇØ ¸é¿ª ȯ°æÀ» ¼öÁ¤ÇÏ´Â ´É·ÂÀ» °¡Áö°í Àֱ⠶§¹®¿¡ Çö´ë Á¾¾çÇп¡¼­ ¸Å¿ì Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2023³â
¿¹Ãø ¿¬µµ 2024³â-2032³â
½ÃÀÛ ±Ý¾× 2,177¾ï ´Þ·¯
¿¹»ó ±Ý¾× 3,887¾ï ´Þ·¯
CAGR 6.7%

ºÏ¹Ì°¡ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀåÀ» Àå¾ÇÇϰí ÀÖÀ¸¸ç 2032³â¿¡´Â 1,783¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹Àº 2023³â 912¾ï ´Þ·¯ ½ÃÀåÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÁÖ·Î ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü¿¡ ±âÀÎÇÕ´Ï´Ù. ¿©·¯ ¸¸¼º ÁúȯÀ» ¾Î°í Àִ ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ Áö¿ªÀÇ ¸é¿ª Á¶Àý Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ¿© ½ÃÀå ¼ºÀå°ú ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Á¦Ç° À¯Çüº°, 2021-2032³â

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¿ëµµº°, 2021-2032³â

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : À¯Åë ä³Îº°, 2021-2032³â

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦9Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Immunomodulators Market was valued at USD 217.7 billion in 2023 and is projected to grow at a CAGR of 6.7% from 2024 to 2032. Immunomodulators, which can either enhance (immunostimulants) or suppress (immunosuppressants) immune system activity, are essential for treating conditions such as autoimmune diseases, cancer, and chronic infections. Several factors drive the market growth, including the increasing prevalence of autoimmune and inflammatory diseases, ongoing advancements in biotechnology and pharmaceutical research, and a growing awareness of immunomodulatory therapies. Rising healthcare expenditures and the growing need for effective treatments also contribute to the market expansion. Additionally, the surge in post-COVID complications has further accelerated the demand for immunomodulators, as these therapies are being used to manage long-term respiratory issues and other health challenges.

The market is divided into two major product types: immunosuppressants and immunostimulants. Immunosuppressants, which accounted for the largest revenue share of USD 136.5 billion in 2023, are projected to grow steadily over the forecast period. This growth is driven by an increased demand for organ transplant medications as the global rate of organ transplants continues to rise. Immunosuppressants play a vital role in preventing organ rejection and ensuring transplant success.

When segmented by application, the immunomodulators market includes oncology, autoimmune diseases, infectious diseases, and other applications. The oncology segment led the market in 2023, valued at USD 85.4 billion. Immunomodulators are increasingly being used in cancer treatment to help strengthen the immune system's ability to target and destroy cancer cells. These therapies, which include immune checkpoint inhibitors, cytokines, and cancer vaccines, are becoming crucial in modern oncology for their ability to modify the immune environment to fight tumors more effectively.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$217.7 Billion
Forecast Value$388.7 Billion
CAGR6.7%

North America is expected to dominate the immunomodulators market, with projections reaching USD 178.3 billion by 2032. The U.S. generated USD 91.2 billion in 2023, primarily due to the high prevalence of chronic diseases. The growing number of individuals living with multiple chronic conditions is significantly increasing the demand for immunomodulatory treatments in the region, driving market growth and innovation.

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 9 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â